Elkana, Israel

Moshe Yeshurun

This inventor holds 5 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent and 1 EPO patent. Top assignees: Mor Research Applications Ltd., Stero Biotechs Ltd.. Active years: 2018-2022.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Moshe Yeshurun. Retrieved from https://idiyas.com/inventor/moshe-yeshurun

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 5 

% Patents Active = 100.0

 

 

Average Co-Inventor Count = 1.1

ph-index = 1

Forward Citations = 4(Granted Patents)


Company Filing History:


Years Active: 2018-2022

Loading Chart...
Loading Chart...
Loading Chart...
5 patents (USPTO):Explore Patents

Title: The Innovations of Moshe Yeshurun

Introduction

Moshe Yeshurun is a notable inventor based in Elqana, Israel. He has made significant contributions to the field of medicine, particularly in the treatment of graft-versus-host disease (GVHD). With a total of five patents to his name, Yeshurun's work focuses on the therapeutic applications of Cannabidiol.

Latest Patents

Yeshurun's latest patents include innovative methods for enhancing the therapeutic effect of steroids through Cannabidiol compositions. His inventions provide methods for preventing, ameliorating, and treating both acute and chronic forms of graft-versus-host disease. These advancements highlight the potential of Cannabidiol in medical treatments.

Career Highlights

Throughout his career, Yeshurun has worked with several companies, including Mor Research Applications Ltd. and Stero Biotechs Ltd. His experience in these organizations has contributed to his expertise in developing effective treatments for complex medical conditions.

Collaborations

Yeshurun has collaborated with Sari Prutchi Sagiv, further enhancing his research and development efforts in the field of medicine.

Conclusion

Moshe Yeshurun's innovative work in the application of Cannabidiol for treating graft-versus-host disease showcases his dedication to advancing medical science. His contributions are paving the way for new therapeutic options in healthcare.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…